Buscar
Mostrando ítems 61-70 de 122
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile
(Oxford University Press for the Infectious Diseases Society of America, 2022)
Background Inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been widely implemented in low- and middle-income countries. However, immunogenicity in immunocompromised patients has not ...
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
(2021)
Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are actively carried out around the world. Several vaccines are currently approved for emergency use in the population, ...
SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study
(2022)
Solid-organ transplant (SOT) recipients have worse COVID-19 outcomes than general population and effective immunisation in these patients is essential but more difficult to reach. We aimed to determine the immunogenicity ...
Microemulsion copolymerization of vinyl acetate and butyl acrylate using a mixture of anionic and non-ionic surfactants
(2011)
Monomer mixtures of vinyl acetate (VAc)/butyl acrylate (BuA) were polymerized in batch reactions at 60 °C with potassium persulfate as the initiator in microemulsions consisting of VAc:BuA (85:15 wt/wt)/water/sodium dodecyl ...
Microemulsion copolymerization of vinyl acetate and butyl acrylate using a mixture of anionic and non-ionic surfactants
(2011)
Monomer mixtures of vinyl acetate (VAc)/butyl acrylate (BuA) were polymerized in batch reactions at 60 °C with potassium persulfate as the initiator in microemulsions consisting of VAc:BuA (85:15 wt/wt)/water/sodium dodecyl ...